Indicator full name: Age-standardized prevalence of current tobacco smoking among people aged 15 years and over, males (WHO estimates) (%)
Unit: %
Dimensions:
- Country/Area (COUNTRY/AREA)
- Supranational group of countries (COUNTRY_GRP)
- Year of measure (YEAR)
Years data is available: 2013—2016
Indicator is part of data set(s):
Last updated: 17 October 2019
Export to:
A critical error happened while trying to prepare the export files.
Sorry for the inconvenience, the support team is already notified about this issue. Please try again later.
Countries with no data (5):
- Monaco
- North Macedonia
- San Marino
- Tajikistan
- Turkmenistan
-
SDR(30-44), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
MDB
-
Data collection on number of drug prescriptions to children and adolescents under 18
BaselineSurvey
-
SDR(1-19), All causes, per 100 000
MDB
-
mHealth programmes for health call centres/health care telephone helpline (operating levels and types)
eHealth
-
SDR(25-64), Asthma, per 100 000
MDB
-
Differences in feeling dizzy, by FAS
HBSC
-
SDR(65+), Suicide and intentional self-harm, per 100 000
MDB
-
% of total energy available from protein
HFA-DB
-
Use of national EHR system by other care facilities, and proportion using it
eHealth
-
SDR(5-14), Accidental poisoning, per 100 000
MDB
-
SDR(60-74), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
MDB
-
Proportion of institutions or associations offering in-service training in the use of ICT for health as part of the continuing education of health professionals
eHealth
-
SDR(0-14), Malignant neoplasm of breast, per 100 000
MDB
-
Deaths(#), Homicide and assault
MDB
-
SDR, external causes of injury and poisoning, 0–64, per 100 000
HFA-DB
-
SDR, all causes, 0–64, per 100 000, females
HFA-DB
-
SDR, cancer of the cervix uteri, 65+, per 100 000
HFA-DB
-
Watching television
HBSC
-
Number of new cases of trachea, bronchus and lung cancer, females
HFA-DB
-
Use of national EHR system by tertiary care facilities, and proportion using it
eHealth
-
Age-standardized prevalence of current tobacco smoking among males aged ≥ 15 years, WHO estimates (Line chart)
-
Age-standardized prevalence of current tobacco smoking among people aged 15 years and over, males (WHO estimates) (%) (Map)
See full graph
Back to preview
Indicators for Health 2020
http://www.euro.who.int/en/health-topics/health-policy/health-2020-the-european-policy-for-health-and-well-being
Health 2020 core indicators were agreed by the WHO European Region Member States for monitoring progress towards the Health 2020 targets. Some of these indicators are based on official WHO sources and other are based on non-WHO sources, such as UNESCO and UNDP. Data from WHO sources can be accessed and queried at national level, while data from non-WHO sources is available in aggregated form, for groups of Member States.
Further information: DIR@euro.who.int
Indicators: 49
Updated: 17 October 2019
Contact:
http://www.euro.who.int/en/health-topics/health-policy/health-2020-the-european-policy-for-health-and-well-being
Health 2020 core indicators were agreed by the WHO European Region Member States for monitoring progress towards the Health 2020 targets. Some of these indicators are based on official WHO sources and other are based on non-WHO sources, such as UNESCO and UNDP. Data from WHO sources can be accessed and queried at national level, while data from non-WHO sources is available in aggregated form, for groups of Member States.
Further information: DIR@euro.who.int
Joint Monitoring Framework (JMF)
The joint monitoring framework (JMF) is used for reporting on indicators under three monitoring frameworks: the Sustainable Development Goals (SDGs), Health 2020 and the Global Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) 2013–2020. The Regional Committee for Europe adopted the JMF in September 2018.
The majority of JMF indicators in the Gateway are linked to existing databases in the Gateway.
Background documents
EUR/RC68/10 Rev.1 Briefing note on the expert group deliberations and recommended common set of indicators for a joint monitoring framework
http://www.euro.who.int/en/about-us/governance/regional-committee-for-europe/past-sessions/68th-session/documentation/working-documents/eurrc6810-
EUR/RC68(1): Joint monitoring framework in the context of the roadmap to implement the 2030 Agenda for Sustainable Development, building on Health 2020, the European policy for health and well-being
http://www.euro.who.int/en/about-us/governance/regional-committee-for-europe/past-sessions/68th-session/documentation/resolutions/eurrc68d1
Developing a common set of indicators for the joint monitoring framework for SDGs, Health 2020 and the Global NCD Action Plan (2017)
http://www.euro.who.int/en/health-topics/health-policy/health-2020-the-european-policy-for-health-and-well-being/publications/2018/developing-a-common-set-of-indicators-for-the-joint-monitoring-framework-for-sdgs,-health-2020-and-the-global-ncd-action-plan-2017
The joint monitoring framework (JMF) is used for reporting on indicators under three monitoring frameworks: the Sustainable Development Goals (SDGs), Health 2020 and the Global Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) 2013–2020. The Regional Committee for Europe adopted the JMF in September 2018.
The majority of JMF indicators in the Gateway are linked to existing databases in the Gateway.
Background documents
EUR/RC68/10 Rev.1 Briefing note on the expert group deliberations and recommended common set of indicators for a joint monitoring framework
http://www.euro.who.int/en/about-us/governance/regional-committee-for-europe/past-sessions/68th-session/documentation/working-documents/eurrc6810-
EUR/RC68(1): Joint monitoring framework in the context of the roadmap to implement the 2030 Agenda for Sustainable Development, building on Health 2020, the European policy for health and well-being
http://www.euro.who.int/en/about-us/governance/regional-committee-for-europe/past-sessions/68th-session/documentation/resolutions/eurrc68d1
Developing a common set of indicators for the joint monitoring framework for SDGs, Health 2020 and the Global NCD Action Plan (2017)
http://www.euro.who.int/en/health-topics/health-policy/health-2020-the-european-policy-for-health-and-well-being/publications/2018/developing-a-common-set-of-indicators-for-the-joint-monitoring-framework-for-sdgs,-health-2020-and-the-global-ncd-action-plan-2017
Targets and indicators for Health 2020 version 3:
http://www.euro.who.int/en/health-topics/health-policy/health-2020-the-european-policy-for-health-and-well-being/publications/2016/targets-and-indicators-for-health-2020.-version-3-2016
European Health Information Initiative:
http://www.euro.who.int/en/data-and-evidence/european-health-information-initiative-ehii
The European Health Statistics App:
http://www.euro.who.int/en/data-and-evidence/the-european-health-statistics-app
(2) 1.1.b. Age-standardized prevalence of current (includes both daily and nondaily or occasional) tobacco use among people aged 18 years and over
The prevalence of current tobacco use among adults is an important measure of the health and economic burden of tobacco, and provides a baseline for evaluating the effectiveness of tobacco control programmes over time. Adjusted and age-standardized prevalence rates are constructed solely for the purpose of comparing tobacco-use prevalence estimates across multiple countries or across multiple time periods for the same country. These rates should not be used to estimate the number of smokers in the population.
Current prevalence estimates for use of any tobacco product are derived from the results of the latest adult tobacco-use survey (or a survey that asks tobaccouse questions), adjusted using the WHO regression method for standardization described in the section on method of estimation below. “Tobacco use” includes cigarettes, cigars, pipes or any other tobacco products. “Current use” includes both daily and non-daily or occasional use.
1) Current tobacco use includes both daily use and non-daily or occasional use. 2) The Health 2020 definition for this indicator is current tobacco use among people aged 18 years and over. The definition applied in the source from which these data were taken is not completely identical (tobacco smoking instead of tobacco use and in people aged 15 years and over instead of in people aged 18 years and over). 3) The data presented here are WHO estimates, and not official statistics reported by countries to WHO.
http://www.euro.who.int/en/health-topics/health-policy/health-2020-the-european-policy-for-health-and-well-being/publications/2016/targets-and-indicators-for-health-2020.-version-3-2016
European Health Information Initiative:
http://www.euro.who.int/en/data-and-evidence/european-health-information-initiative-ehii
The European Health Statistics App:
http://www.euro.who.int/en/data-and-evidence/the-european-health-statistics-app
(2) 1.1.b. Age-standardized prevalence of current (includes both daily and nondaily or occasional) tobacco use among people aged 18 years and over
The prevalence of current tobacco use among adults is an important measure of the health and economic burden of tobacco, and provides a baseline for evaluating the effectiveness of tobacco control programmes over time. Adjusted and age-standardized prevalence rates are constructed solely for the purpose of comparing tobacco-use prevalence estimates across multiple countries or across multiple time periods for the same country. These rates should not be used to estimate the number of smokers in the population.
Current prevalence estimates for use of any tobacco product are derived from the results of the latest adult tobacco-use survey (or a survey that asks tobaccouse questions), adjusted using the WHO regression method for standardization described in the section on method of estimation below. “Tobacco use” includes cigarettes, cigars, pipes or any other tobacco products. “Current use” includes both daily and non-daily or occasional use.
1) Current tobacco use includes both daily use and non-daily or occasional use. 2) The Health 2020 definition for this indicator is current tobacco use among people aged 18 years and over. The definition applied in the source from which these data were taken is not completely identical (tobacco smoking instead of tobacco use and in people aged 15 years and over instead of in people aged 18 years and over). 3) The data presented here are WHO estimates, and not official statistics reported by countries to WHO.
Country/Area notes
No information